Akili’s Video Game Therapy Hits Goal In Pivotal ADHD Trial

Trial sets of Akili Interactive’s video game digital medicine has hit its goal of improving attention and inhibitory control in children with attention deficit hyperactivity disorder (ADHD). The video game –  AKL-T01 – is played on a tablet device.

While it plays like a classic video game, AKL-T01 utilizes algorithms and other methods that act on the neural system in order to adjust stimulus levels as needed for the consumer. After four weeks of using AKL-T01, consumers using the game were found to perform better on the attention performance index. Akili’s next step is to file for . . .